Upfront Docetaxel in the Post-STAMPEDE World: Lessons from an Early Evaluation of Non-trial Usage in Hormone-Sensitive Prostate Cancer
- PMID: 28652092
- DOI: 10.1016/j.clon.2017.06.006
Upfront Docetaxel in the Post-STAMPEDE World: Lessons from an Early Evaluation of Non-trial Usage in Hormone-Sensitive Prostate Cancer
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
